Available in the form of shots, Synagis
® (
palivizumab) is given to infants or young children who have a high risk for developing serious complications from respiratory syncytial virus (
RSV). These injections are given once a month during RSV season, which is usually from November to April. Although this prescription medication cannot prevent an RSV infection, it can help to minimize serious problems this infection can cause.
Synagis shots are typically used in infants and young children age 24 months and younger; they are not approved for use in adults. A healthcare provider will usually give these injections, although you may be taught how to give them at home.
(For more details on these shots, click Synagis. This Web page offers a closer look at specific benefits of this drug, how it works, and why it may not be a good choice for some children.)
HealthSavvy Sign In
|